Charlson comorbidity Index for descriptive risk stratification of long-term All-cause mortality in elderly patients with acute myocardial infarction: a retrospective cohort study - Summary - MDSpire
Advertisement
Charlson comorbidity Index for descriptive risk stratification of long-term All-cause mortality in elderly patients with acute myocardial infarction: a retrospective cohort study
To describe the association between CCI-defined comorbidity burden and long-term all-cause mortality in elderly patients with acute myocardial infarction (AMI).
Approach:
Study Design: Retrospective cohort study of 350 elderly patients (age ≥65 years) admitted with AMI.
Data Collection: CCI scores calculated from admission records; patients stratified into low, moderate, and high comorbidity groups.
Statistical Analysis: Cox proportional hazards models used to assess the association between CCI and long-term all-cause mortality.
Key Findings:
28.0% of patients died during a median follow-up of 40.9 months (range: 1.4–57.5 months).
All-cause mortality increased with higher CCI scores: 16.95% (low, CCI 1–2), 29.58% (moderate, CCI 3–4), 40.00% (high, CCI ≥5); Log-rank P < 0.001.
Univariable analysis showed CCI score significantly associated with all-cause mortality (HR = 1.164, 95% CI 1.059–1.278, P = 0.002).
In multivariable analysis, CCI did not reach statistical significance after adjustment for confounders (HR = 1.089, P = 0.125).
Smoking history was independently associated with worse prognosis (HR = 1.862, P = 0.003), while PCI receipt was associated with lower mortality (HR = 0.497, P = 0.001).
Interpretation:
Higher CCI scores correlate with increased long-term all-cause mortality in univariable analyses, but CCI's independent predictive ability is not confirmed after multivariable adjustment.
Limitations:
Observational study design may introduce biases and limit causal inferences.
CCI was not independently associated with long-term mortality after adjustment.
Subgroup analyses were exploratory and not intended to establish independent predictive ability.
Conclusion:
Routine CCI assessment may help characterize comorbidity burden, but individualized risk assessment should consider multiple clinical factors.